On behalf of the Chairman, Sudhir Diwan, MD, and Course Directors, Scott Woska, MD and Christopher Gharibo, MD and the New York and New Jersey Societies of Interventional Pain Physicians (NYSIPP & NJSIPP), we would like to invite you to join us at the New York and New Jersey Pain Medicine Symposium 2019: Evolving Advanced Pain Therapies. This year’s meeting is being held November 7-10, 2019 at the Hyatt Regency Jersey City, New Jersey.
The NYSIPP & NJSIPP Pain Medicine Symposium was established in 2011 with the primary objectives of educating health care professionals to promote the development of safe, high quality, and cost effective practice of interventional pain management techniques for the diagnosis and treatment of pain and related disorders, and to insure patient access to these interventions.
Our scientific program will provide cutting edge information on advanced state-of-the-art pain management techniques, advanced regenerative medicine therapies, advanced neuromodulation therapies and beyond, vertebral augmentation, discography and intradiscal procedures, radiofrequency, peripheral nerve stimulation, intrathecal therapy, minimally invasive sacroiliac fusion and for lumbar spinal stenosis. This course will offer a full day hands on cadaver and ultrasound course, incorporating didactic lectures with the hands-on practice for improved technique and patient outcomes for interventional procedures presented by nationally and internationally renowned experts. Additionally, we have focused workshops for residents and fellows, and for nurse practitioners and physician assistants. On Sunday, November 10, we will be offering a full day breakout session on the safe utilization of opioid medication specifically geared for primary care and conventional medical management physicians who require specific training in the prescribing and utilization of opioids and controlled substances.
Industry Partners and technical exhibits are an important part of our meeting’s success and benefit both the attendees and the companies who choose to participate. We anticipate in excess of 600 clinical providers specializing in pain management, interventional pain management and neurosurgery to attend, including physicians, mid-level practitioners, fellows, residents, nurses and pharmacists.
We look forward to seeing you at the 2019 New York and New Jersey Pain Medicine Symposium.
Sudhir Diwan, MD
CEO, NYSIPP, Chairman
Scott Woska, MD
Christopher Gharibo, MD